Actinium Pharmaceuticals (ATNM) Market Capitalization (2012 - 2026)
Actinium Pharmaceuticals (ATNM) reported Market Capitalization of $30.81 million for Q2 2026, down 29.4% from $43.67 million a year earlier and down 1.8% from the prior quarter.
Powered by 
Analysis
Actinium Pharmaceuticals (ATNM) Market Capitalization (2012 - 2026) Analysis & Trends
For FY2025, Actinium Pharmaceuticals posted Market Capitalization of $42.43 million, up 7.9% from FY2024.
- Market Capitalization has a five-year compound annual growth rate of -14.8% (FY2020 to FY2025).
- By year, Market Capitalization came in at $39.31 million in FY2024 (-72.0%), $140.38 million in FY2023 (-48.7%), $273.44 million in FY2022 (+105.5%) and $133.09 million in FY2021 (+40.6%).
- The Q2 2026 figure ranks as the lowest quarterly Market Capitalization in data going back to Q4 2012.
- Year over year, Market Capitalization gained in 1 of the last eight quarters, with an average decline of 46.1%.
- The high point for year-over-year Market Capitalization in five years was Q1 2023 (growth of 114.9%); the low point was Q2 2025 (a decline of 80.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $31.37 million (Q1 2026), $42.43 million (Q4 2025) and $49.91 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Actinium Pharmaceuticals | 36.16 Mn | 36.16 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.81 Mn |
| Mar 31, 2026 | 31.37 Mn |
| Dec 31, 2025 | 42.43 Mn |
| Sep 30, 2025 | 49.91 Mn |
| Jun 30, 2025 | 43.67 Mn |
| Mar 31, 2025 | 50.23 Mn |
| Dec 31, 2024 | 39.31 Mn |
| Sep 30, 2024 | 58.65 Mn |
| Jun 30, 2024 | 226.07 Mn |
| Mar 31, 2024 | 230.17 Mn |
| Dec 31, 2023 | 140.38 Mn |
| Sep 30, 2023 | 162.29 Mn |
| Jun 30, 2023 | 200.22 Mn |
| Mar 31, 2023 | 243.14 Mn |
| Dec 31, 2022 | 273.44 Mn |
| Sep 30, 2022 | 186.07 Mn |
| Jun 30, 2022 | 119.63 Mn |
| Mar 31, 2022 | 113.16 Mn |
| Dec 31, 2021 | 133.09 Mn |
| Sep 30, 2021 | 195.19 Mn |
API Access
Actinium Pharmaceuticals Market Capitalization API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=market-capitalization&ticker=ATNM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "market-capitalization", "ticker": "ATNM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=market-capitalization&ticker=ATNM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();